Facebook Linkedin RSS Twitter Youtube
Home 2014

Sorrento Therapeutics

Soon-Shiong’s NantWorks and Sorrento Ink Cancer Immunotherapy Deal
Cancer

Soon-Shiong’s NantWorks and Sorrento Ink Cancer Immunotherapy Deal

Sorrento Wins Up to $2.6M from NIH to Develop ADCs, Bispecific Antibodies
Drug Discovery

Sorrento Wins Up to $2.6M from NIH to Develop ADCs, Bispecific Antibodies

Sorrento, Morphotek Launch Up to $50M ADC Collaboration
News

Sorrento, Morphotek Launch Up to $50M ADC Collaboration

Sorrento, Scripps Unite to Develop Obesity-Fighting Vaccines and Antibody Therapeutics
Drug Discovery

Sorrento, Scripps Unite to Develop Obesity-Fighting Vaccines and Antibody Therapeutics

Sorrento Licenses Ben-Gurion University HCV Antibody Clones
Drug Discovery

Sorrento Licenses Ben-Gurion University HCV Antibody Clones

Sorrento, Igdrasol Secure Exclusive E.U. Distribution Rights to Cancer Drug
Cancer

Sorrento, Igdrasol Secure Exclusive E.U. Distribution Rights to Cancer Drug

Sorrento Boosts Cancer Pipeline with Igdrasol Purchase
Cancer

Sorrento Boosts Cancer Pipeline with Igdrasol Purchase

Sorrento Wins $600K to Develop MRSA Antibodies that Disrupt Quorum Sensing
Drug Discovery

Sorrento Wins $600K to Develop MRSA Antibodies that Disrupt Quorum Sensing

Sorrento Wins Second NIAID Grant of $600K to Develop Quorum Quenching Antibacterial
Drug Discovery

Sorrento Wins Second NIAID Grant of $600K to Develop Quorum Quenching Antibacterial

12Page 2 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.